Paper20176026
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.
McCarthy JJ and 8 others. Gastroenterology, 2010. Cited by 292 papers, by iCite.
Cite this record
ConductScience Library. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Papers, record 20176026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20176026
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis C, Chronic | Major topic |
| Interferon-alpha | Major topic |
| Interleukins | Major topic |
| Polyethylene Glycols | Major topic |
| Ribavirin | Major topic |
| Adult | |
| Drug Therapy, Combination | |
| Female | |
| Genotype | |
| Hepacivirus | |
| Humans | |
| Interferon alpha-2 | |
| Interferons | |
| Male | |
| Middle Aged | |
| Recombinant Proteins | |
| Viral Load | |
| Interferon Lambda |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UL1 RR024128 | NCRR NIH HHS | United States | UL1RR024128 | PubMed and NIH |
| 1 UL1 RR024128-01 | NCRR NIH HHS | United States | UL1RR024128 | PubMed and NIH |
Source NIH RePORTER
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8049640 | Statistical analysis of molecular epidemiology studies employing case-series. | Cancer Epidemiol Biomarkers Prev | 1994 | https://conductscience.org/library/papers/8049640 | PubMed |
| 2 | 16146571 | Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. | Virol J | 2005 | https://conductscience.org/library/papers/16146571 | PubMed |
| 3 | 19684573 | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. | Nature | 2009 | https://conductscience.org/library/papers/19684573 | PubMed |
| 4 | 17087946 | Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. | Gastroenterology | 2006 | https://conductscience.org/library/papers/17087946 | PubMed |
| 5 | 14996676 | Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. | Ann Intern Med | 2004 | https://conductscience.org/library/papers/14996676 | PubMed |
| 6 | 16702586 | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. | Ann Intern Med | 2006 | https://conductscience.org/library/papers/16702586 | PubMed |
| 7 | 8389799 | Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. | J Gen Virol | 1993 | https://conductscience.org/library/papers/8389799 | PubMed |
| 8 | 12324553 | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12324553 | PubMed |
| 9 | 14681338 | Global burden of disease (GBD) for hepatitis C. | J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14681338 | PubMed |
| 10 | 19749757 | Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. | Nat Genet | 2009 | https://conductscience.org/library/papers/19749757 | PubMed |
| 11 | 10451460 | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10451460 | PubMed |
| 12 | 19749758 | IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. | Nat Genet | 2009 | https://conductscience.org/library/papers/19749758 | PubMed |
| 13 | 15731279 | Lambda interferon inhibits hepatitis B and C virus replication. | J Virol | 2005 | https://conductscience.org/library/papers/15731279 | PubMed |
| 14 | 17569110 | Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. | Stat Med | 2008 | https://conductscience.org/library/papers/17569110 | PubMed |
| 15 | 11583749 | Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. | Lancet | 2001 | https://conductscience.org/library/papers/11583749 | PubMed |
| 16 | 17625010 | Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. | J Transl Med | 2007 | https://conductscience.org/library/papers/17625010 | PubMed |
| 17 | 8122051 | Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. | Stat Med | 1994 | https://conductscience.org/library/papers/8122051 | PubMed |
| 18 | 9160492 | A comparison of goodness-of-fit tests for the logistic regression model. | Stat Med | 1997 | https://conductscience.org/library/papers/9160492 | PubMed |
| 19 | 10084106 | Allelic discrimination using fluorogenic probes and the 5' nuclease assay. | Genet Anal | 1999 | https://conductscience.org/library/papers/10084106 | PubMed |
Cited by103
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 292 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32125935 | A review of clinical pharmacogenetics Studies in African populations. | Per Med | 2020 | https://conductscience.org/library/papers/32125935 | PubMed |
| 31551080 | Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran. | BMC Res Notes | 2019 | https://conductscience.org/library/papers/31551080 | PubMed |
| 31019253 | The remarkable history of the hepatitis C virus. | Genes Immun | 2019 | https://conductscience.org/library/papers/31019253 | PubMed |
| 30987134 | Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay? | Cells | 2019 | https://conductscience.org/library/papers/30987134 | PubMed |
| 29517696 | Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/29517696 | PubMed |
| 29104462 | Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy. | Int J Med Sci | 2017 | https://conductscience.org/library/papers/29104462 | PubMed |
| 28962822 | High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan. | Kaohsiung J Med Sci | 2017 | https://conductscience.org/library/papers/28962822 | PubMed |
| 28588752 | Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review. | World J Hepatol | 2017 | https://conductscience.org/library/papers/28588752 | PubMed |
| 28144454 | Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C. | Iran Red Crescent Med J | 2016 | https://conductscience.org/library/papers/28144454 | PubMed |
| 28123444 | The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection. | Hepat Mon | 2016 | https://conductscience.org/library/papers/28123444 | PubMed |
| 27877087 | IL28B SNP rs12979860 is the Critical Predictor for Sustained Viral Response in Chinese Children Aged 1 to 6 Years with Chronic Hepatitis C. | Int J Biol Sci | 2016 | https://conductscience.org/library/papers/27877087 | PubMed |
| 27785282 | Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment. | Gastroenterology Res | 2014 | https://conductscience.org/library/papers/27785282 | PubMed |
| 27560987 | Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients. | Genet Mol Biol | 2016 | https://conductscience.org/library/papers/27560987 | PubMed |
| 27544760 | Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. | Arch Virol | 2016 | https://conductscience.org/library/papers/27544760 | PubMed |
| 27308262 | Prevalence of interleukin-28B single nucleotide polymorphism genotypes in patients with hepatitis C infection in Isfahan, Iran. | Adv Biomed Res | 2016 | https://conductscience.org/library/papers/27308262 | PubMed |
| 27307212 | IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection. | Genes Immun | 2016 | https://conductscience.org/library/papers/27307212 | PubMed |
| 27271956 | Distribution of IL28B Polymorphism in a Cohort of Italians and Immigrants with HCV Infection: Association with Viraemia, Stage of Fibrosis and Response to Treatment. | J Immigr Minor Health | 2017 | https://conductscience.org/library/papers/27271956 | PubMed |
| 27186094 | Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies. | J Exp Pharmacol | 2010 | https://conductscience.org/library/papers/27186094 | PubMed |
| 26678941 | The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response. | Kaohsiung J Med Sci | 2015 | https://conductscience.org/library/papers/26678941 | PubMed |
| 26468348 | Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city. | Gastroenterol Hepatol Bed Bench | 2015 | https://conductscience.org/library/papers/26468348 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| IFNL1 | 282618 | PubTator's text mining | https://conductscience.org/library/genes/282618 | NCBI Gene |
| IFNL2 | 282616 | PubTator's text mining | https://conductscience.org/library/genes/282616 | NCBI Gene |
| IFNL3 | 282617 | PubTator's text mining | https://conductscience.org/library/genes/282617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20176026
GET https://conductscience.org/api/papers/v1/20176026/cited_by?page=2